Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$768M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$625M |
| 3 |
AGN
Allergan plc
AGN
|
+$427M |
| 4 |
McKesson
MCK
|
+$427M |
| 5 |
Johnson Controls International
JCI
|
+$427M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$503M |
| 2 |
RTX Corp
RTX
|
+$457M |
| 3 |
Global Payments
GPN
|
+$441M |
| 4 |
Amazon
AMZN
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$355M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.1% |
| 2 | Healthcare | 3.97% |
| 3 | Industrials | 2.85% |
| 4 | Financials | 2.77% |
| 5 | Consumer Discretionary | 2.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
RingCentral
RNG
$4.66B
| $22.1M | 0.01% |
104,290
-165,116
| -61% | -$34M |
|
1077
Armstrong World Industries
AWI
$7.38B
| $22M | 0.01% |
277,495
+230,459
| +490% | +$22.2M |
|
1078
PUT
Carnival Corporation Ltd
CCL
$38.1B
| $22M | 0.01% |
1,673,200
+1,245,300
| +291% | +$44.3M |
|
1079
PUT
T-Mobile US
TMUS
$185B
| $22M | 0.01% |
262,600
-183,600
| -41% | -$15.5M |
|
|
RETA
1080
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $22M | 0.01% |
152,400
+13,600
| +10% | +$2.63M |
|
1081
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $22M | 0.01% |
655,398
+616,422
| +1,582% | +$25.1M |
|
1082
PUT
Public Storage
PSA
$60.5B
| $22M | 0.01% |
110,600
+46,900
| +74% | +$10M |
|
|
STSA
1083
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $22M | 0.01% |
1,020,417
+2,935
| +0.3% | +$66.6K |
|
|
VMW
1084
PUT
DELISTED
VMware, Inc
VMW
| $21.9M | 0.01% |
181,000
-237,400
| -57% | -$32.6M |
|
1085
BioMarin Pharmaceuticals
BMRN
$11.6B
| $21.9M | 0.01% |
259,327
-1,780,826
| -87% | -$153M |
|
|
SCHW
1086
PUT
Charles Schwab
SCHW
$183B
| $21.9M | 0.01% |
651,500
+96,400
| +17% | +$4.05M |
|
1087
Arrow Electronics
ARW
$11.1B
| $21.8M | 0.01% |
420,834
-446,146
| -51% | -$31.7M |
|
|
EVBG
1088
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $21.8M | 0.01% |
205,220
+187,271
| +1,043% | +$18.4M |
|
1089
CALL
iShares Core S&P 500 ETF
IVV
$878B
| $21.8M | 0.01% |
84,400
+80,200
| +1,910% | +$24.6M |
|
|
GTLS
1090
DELISTED
Chart Industries
GTLS
| $21.8M | 0.01% |
752,278
+23,716
| +3% | +$1.29M |
|
|
FISV
1091
CALL
Fiserv Inc
FISV
$28.8B
| $21.8M | 0.01% |
229,200
+108,300
| +90% | +$12M |
|
1092
CALL
HCA Healthcare
HCA
$87.2B
| $21.8M | 0.01% |
242,100
+62,800
| +35% | +$8.13M |
|
|
VISN
1093
Vistance Networks Inc
VISN
$2.65B
| $21.7M | 0.01% |
2,378,077
+991,678
| +72% | +$11.5M |
|
1094
PUT
CSX Corp
CSX
$93.4B
| $21.7M | 0.01% |
1,133,700
-693,300
| -38% | -$16.2M |
|
1095
PUT
Ferrari
RACE
$69.2B
| $21.6M | 0.01% |
141,900
-71,100
| -33% | -$11.5M |
|
1096
Invesco S&P 500 Equal Weight ETF
RSP
$97B
| $21.6M | 0.01% |
256,640
+240,396
| +1,480% | +$25.5M |
|
1097
CALL
Dollar Tree
DLTR
$24.4B
| $21.5M | 0.01% |
293,100
-3,200
| -1% | -$272K |
|
1098
PUT
LendingTree
TREE
$447M
| $21.5M | 0.01% |
117,300
-47,300
| -29% | -$13.4M |
|
1099
CALL
Edwards Lifesciences
EW
$49.6B
| $21.5M | 0.01% |
341,400
-84,900
| -20% | -$6.12M |
|
1100
TG Therapeutics
TGTX
$7.96B
| $21.5M | 0.01% |
2,180,717
+1,196,536
| +122% | +$15.1M |
|
Similar funds
Citadel Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, Citadel Advisors held 10,687 positions worth $222B, down 3.5% from $230B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Citadel Advisors deployed $36.9B of net new capital in Q1 2020, opening 1,650 new positions and adding to 4,224 existing holdings. Its largest new stake was Invesco QQQ Trust: 2,950,335 shares worth $562M.
By sector, the portfolio is most concentrated in Technology at 4.1% of assets, down from 5.1% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Uber, an estimated $503M trimmed.
- Citadel Advisors's largest Q1 2020 buy was Invesco QQQ Trust: 2,950,335 shares worth $562M.
- Citadel Advisors added most to Charter Communications in Q1 2020, an estimated $768M increase.
- Citadel Advisors's biggest Q1 2020 reduction was Uber, cutting an estimated $503M.
- Citadel Advisors fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $280M.
- Citadel Advisors's ten largest holdings make up 32% of its $222B portfolio in Q1 2020.
- Citadel Advisors opened 1,650 new positions and closed 1,165 in Q1 2020.
- Citadel Advisors's portfolio value fell 3.5% quarter-over-quarter to $222B.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.